SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,598 | +26.1% | 10,359 | +65.7% | 0.00% | 0.0% |
| Q1 2023 | $226,438 | +5.1% | 6,250 | +3.5% | 0.00% | 0.0% |
| Q4 2022 | $215,483 | +7.7% | 6,041 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $200,000 | +115.1% | 5,914 | +84.6% | 0.00% | 0.0% |
| Q2 2022 | $93,000 | -3.1% | 3,204 | +7.4% | 0.00% | 0.0% |
| Q1 2022 | $96,000 | +190.9% | 2,983 | +163.3% | 0.00% | – |
| Q4 2021 | $33,000 | +17.9% | 1,133 | +8.7% | 0.00% | – |
| Q3 2021 | $28,000 | 0.0% | 1,042 | +16.3% | 0.00% | – |
| Q2 2021 | $28,000 | +16.7% | 896 | -2.2% | 0.00% | – |
| Q1 2021 | $24,000 | +242.9% | 916 | +233.1% | 0.00% | – |
| Q4 2020 | $7,000 | +40.0% | 275 | +22.2% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 225 | +28.6% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 175 | +34.6% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 130 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | +300.0% | 130 | +766.7% | 0.00% | – |
| Q2 2018 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |